GMAB vs ONC

Genmab A/S and BeOne Medicines AG, both Healthcare

BeOne Medicines AG is the larger company at $46B against $33B. Over the past year GMAB returned +75% against +23% for ONC.

Genmab A/S and BeOne Medicines AG compared on valuation multiples, growth, margins and return
FigureGMABONC
Last close$50.98$404
Market cap$33B$46B
Trailing P/E33.2n/a
Revenue growth+19%n/a
Operating margin29%n/a
Net margin26%n/a
Free cash flow yield3.5%n/a
Net cash$3.6B net debtn/a
Insiders, 12 monthsn/asold $392M net
1-year return+75%+23%
5-year return+9.6%+8.0%

Figures from SEC filings and end-of-day closes. Highlighting marks the higher number in each row, nothing more.

Genmab A/S

Revenue of $2.1B in the quarter to Dec 31, 2025, net income $432M.

BeOne Medicines AG

Open these two in the interactive comparison to add more names, change the period or see the correlation.